MEISSA Trademark

Trademark Overview

On Tuesday, March 10, 2020, a trademark application was filed for MEISSA with the United States Patent and Trademark Office. The USPTO has given the MEISSA trademark a serial number of 88829074. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Meissa Vaccines, Inc.. The MEISSA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
meissa

General Information

Serial Number88829074
Word MarkMEISSA
Filing DateTuesday, March 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesVaccines
Translation of Words in MarkThe English translation of "MEISSA" is "paradigm"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeissa Vaccines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameMeissa Vaccines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, May 29, 2020NON-FINAL ACTION WRITTEN
Friday, March 13, 2020NEW APPLICATION ENTERED
Tuesday, March 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 29, 2020ASSIGNED TO EXAMINER
Friday, May 29, 2020NON-FINAL ACTION E-MAILED
Friday, May 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, July 31, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Friday, July 31, 2020ASSIGNED TO LIE
Friday, July 31, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 26, 2021SOU EXTENSION 1 FILED
Monday, April 26, 2021SOU TEAS EXTENSION RECEIVED
Monday, April 26, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021SOU EXTENSION 2 FILED
Tuesday, October 19, 2021SOU EXTENSION 2 GRANTED
Monday, April 25, 2022SOU EXTENSION 3 GRANTED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 25, 2022SOU EXTENSION 3 FILED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 4 FILED
Wednesday, October 26, 2022SOU EXTENSION 4 GRANTED
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2023SOU EXTENSION 5 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 20, 2023SOU EXTENSION 5 GRANTED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

meissa vaccines